These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 3855261)
1. Natural killer cell-mediated cytotoxicity does not depend on recognition of mannose 6-phosphate residues. Haubeck HD; Kölsch E; Imort M; Hasilik A; von Figura K J Immunol; 1985 Jan; 134(1):65-9. PubMed ID: 3855261 [TBL] [Abstract][Full Text] [Related]
2. Studies on natural, antibody-dependent, and interleukin-2-activated killer-cell activity of a patient with mucolipidosis III as a test of the mannose-6-phosphate lytic acceptor hypothesis. Werkmeister JA; Pross HF J Clin Immunol; 1985 Jul; 5(4):228-38. PubMed ID: 2931446 [TBL] [Abstract][Full Text] [Related]
3. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation. Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943 [TBL] [Abstract][Full Text] [Related]
4. Antagonistic effects of interferons on the cytotoxicity mediated by natural killer cells. Trinchieri G; Santoli D; Granato D; Perussia B Fed Proc; 1981 Oct; 40(12):2705-10. PubMed ID: 6169557 [TBL] [Abstract][Full Text] [Related]
5. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis]. Guo KY; Mei JZ; Yao KT Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963 [TBL] [Abstract][Full Text] [Related]
6. Antileukemia activity of a natural killer cell line against human leukemias. Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753 [TBL] [Abstract][Full Text] [Related]
7. Resistance against natural killer cell cytotoxicity: analysis of mechanisms. Hasenkamp J; Borgerding A; Wulf G; Uhrberg M; Jung W; Dingeldein S; Truemper L; Glass B Scand J Immunol; 2006 Oct; 64(4):444-9. PubMed ID: 16970688 [TBL] [Abstract][Full Text] [Related]
8. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1. Pérez-Villar JJ; Melero I; Navarro F; Carretero M; Bellón T; Llano M; Colonna M; Geraghty DE; López-Botet M J Immunol; 1997 Jun; 158(12):5736-43. PubMed ID: 9190923 [TBL] [Abstract][Full Text] [Related]
10. Human epidermal cells and squamous carcinoma cells synthesize a cytokine that augments natural killer cell activity. Luger TA; Uchida A; Köck A; Colot M; Micksche M J Immunol; 1985 Apr; 134(4):2477-83. PubMed ID: 3882831 [TBL] [Abstract][Full Text] [Related]
11. Natural killer cell mediated cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L-mediated endogenous production of interleukin-12. Bose A; Baral R Hum Immunol; 2007 Oct; 68(10):823-31. PubMed ID: 17961770 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of resistance to natural killer cell-mediated cytotoxicity in acute lymphoblastic leukemia. Romanski A; Bug G; Becker S; Kampfmann M; Seifried E; Hoelzer D; Ottmann OG; Tonn T Exp Hematol; 2005 Mar; 33(3):344-52. PubMed ID: 15730858 [TBL] [Abstract][Full Text] [Related]
13. [Inhibition of natural killer and interleukin 2-activated natural killer cell cytotoxicity by monosaccharides and lectins]. Imir T; Bankhurst AD Mikrobiyol Bul; 1987 Oct; 21(4):245-50. PubMed ID: 3509759 [TBL] [Abstract][Full Text] [Related]
14. In vitro enhancement of peripheral blood mononuclear cell natural killer activity following short term incubation with fetal calf serum. Lauer SJ; Finlan J; Borella LD; Piaskowski VD; Casper JT J Clin Lab Immunol; 1983 Oct; 12(2):105-10. PubMed ID: 6606047 [TBL] [Abstract][Full Text] [Related]
15. NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells. Kurago ZB; Lutz CT; Smith KD; Colonna M J Immunol; 1998 Feb; 160(4):1573-80. PubMed ID: 9469412 [TBL] [Abstract][Full Text] [Related]
16. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells. El-Sherbiny YM; Meade JL; Holmes TD; McGonagle D; Mackie SL; Morgan AW; Cook G; Feyler S; Richards SJ; Davies FE; Morgan GJ; Cook GP Cancer Res; 2007 Sep; 67(18):8444-9. PubMed ID: 17875681 [TBL] [Abstract][Full Text] [Related]
17. Thrombin modulation of natural killer activity in human peripheral lymphocytes. Naldini A; Carney DH Cell Immunol; 1996 Aug; 172(1):35-42. PubMed ID: 8806804 [TBL] [Abstract][Full Text] [Related]
18. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF). Wright SC; Bonavida B J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909 [TBL] [Abstract][Full Text] [Related]
19. The effects of hexose 6-O-sulfate esters on human natural killer cell lytic function. Chambers WH; Oeltmann TN J Immunol; 1986 Sep; 137(5):1469-74. PubMed ID: 3462244 [TBL] [Abstract][Full Text] [Related]
20. Quantitative and functional studies of impaired natural killer (NK) cells in patients with myelofibrosis, essential thrombocythemia, and polycythemia vera. I. A potential role for platelet-derived growth factor in defective NK cytotoxicity. Gersuk GM; Carmel R; Pattamakom S; Challita PM; Rabinowitz AP; Pattengale PK Nat Immun; 1993; 12(3):136-51. PubMed ID: 8329837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]